Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 351 - 400 out of 12,630

Document Document Title
WO/2013/114223A3
The present invention relates to a process for producing a syrup which is rich in maltitol. The process is comprising the successive steps of liquefaction of a starch milk and saccharification of the liquefied starch milk in the presence...  
WO/2013/115157A1
Disclosed are: a pharmaceutical composition containing a compound represented by general formula (I) or a physiologically acceptable salt thereof as an active ingredient; and a method for treating cancer, characterized by administering a...  
WO/2013/110704A1
The present invention relates to novel compounds prepared from readily accessible 3-O-propargyl-D-galactopyranoside derivatives and having an effect as i.a., galectin inhibitors, the use of said compounds as a medicament as well as for t...  
WO/2013/108794A1
Provided is a polynucleotide that encodes a protein having the activity of transferring a sugar to a hydroxyl group at the 4'-position of a flavone. This polynucleotide is selected from the group consisting of: (a) a polynucleotide compr...  
WO/2013/102793A3
A novel process for preparation of Rebaudioside D (RD), and other related naturally occurring sweeteners is provided. RD is a natural sweetening agent which can decrease the bitter aftertaste of steviol glycosides. The said process is su...  
WO/2013/097942A1
Sialic acid derivatives of the formula (I), in which the symbols have the meanings specified in the description, are suitable as pharmaceuticals, in particular for diseases having a course influenced by siglec ligands.  
WO/2013/096926A1
Methods and compositions using E-selectin antagonists are provided for the treatment and prevention of diseases and disorders treatable by inhibiting binding of E-selectin to an E-selectin ligand. Described herein are E-selectin antagoni...  
WO/2013/091660A1
A mixture of, preferably a mixture consisting essentially of, an lacto-N-tetraose (LNT) precursor (1) and an lacto-N-neotetraose (LNnT) precursor (2), (formula 1, 2), where R is a group removable by hydrogenolysis and R3 is either a grou...  
WO/2013/093320A1
The invention relates to the use of 1-aryl-2-aryloxyethane compounds with formula I, wherein n and m are equal to 0 or 1, provided that n+m=1, R1 and R2 particularly representing hydrogen atoms, R3 and R4 particularly representing hydrog...  
WO/2013/088246A3
There is provided processes for the purification of rebaudioside A from Steviol glycoside compositions, such as Stevia extracts. Also provided are pure compositions and formulations thereof of rebaudioside A with traces amounts of remain...  
WO/2013/090296A1
Nucleic acid molecules and compositions comprising: a nucleic acid sequence that encodes IL-12 p35 subunit or a functional fragment thereof and/or a nucleic acid sequence that encodes IL-12 p40 subunit or a functional fragment thereof, a...  
WO/2013/086131A1
Provided are compounds according to formula (la) or (lb) as described herein, that are capable of modulating the activity of influenza viruses (e.g., influenza A virus), for example, via interaction with the M2 transmembrane protein, and...  
WO/2013/077433A1
The purpose of the present invention is to provide a keratoconjunctival protecting agent or a keratoconjunctival disorder inhibiting agent having an outstanding effect in suppressing keratoconjunctival disorders. This invention comprises...  
WO/2013/073659A1
Provided is a method for producing a glycoside having a phenol as the aglycone thereof, which is a method that: does not require an expensive catalyst or enzyme; does not require following a complex synthesis pathway; is a method for dir...  
WO/2013/073657A1
Provided is a method for directly producing an oligoglucoside from a saccharide chain including glucose as a constitutional unit thereof, by: reacting a saccharide chain including glucose as a constitutional unit thereof with a compound ...  
WO/2013/072355A1
The present invention relates to new anti-infectious compounds consisting of (i) a polar head having from one to three mannose, dimannose or trimannose moieties, which is coupled through an appropriate linker to (ii) a single lipid chain...  
WO/2013/071409A1
A novel lipoteichoic acid (LTA) was isolated from C. difficile, the structure of which is illustrated below wherein n is an interger between 1 and 20, R3 and R4 are independently selected from C 14:0, C 16:0, C 16: l, C 18:0 or C18: l fa...  
WO/2013/065383A1
A compound represented by structural formula (A) or a salt thereof. The compound or the salt thereof is produced suitably from a microorganism belonging to the genus Saccharothrix and can be used suitably as a prostaglandin production in...  
WO/2013/059927A1
The present application relates to the compounds of formula I (I) as well as their use for inhibiting at least one of AKT-1, FAK and PKCα and in the treatment and/or prevention of metastatic diseases.  
WO/2013/061816A1
The present description discloses a novel biologically active ingredient of manuka honey. Specifically, the present description discloses a compound represented by formula (AA). (In the formula, each of R1, R2 and R3 independently repres...  
WO/2013/061802A1
The purpose of the present invention is to provide a method for producing a composition containing glyceryl glucoside, which does not undergo discoloration and is gentle to the skin. Provided is a method for producing a composition conta...  
WO/2013/052012A1
The disclosure provides cationic peptidopolysaccharides of Formula I: which has a bacterial peptidoglycan-mimetic structure, and shows outstanding broad spectrum activities against clinically significant bacteria and fungi. The structura...  
WO/2013/052615A1
A method for controlling pests by modifying derivatives of sophoroiipids (SL) and applying the modified sophorolipid derivatives (MSL) to the plant pathogen or to an environment in which the pathogens may occur or are located in an amoun...  
WO/2013/050497A1
The present invention relates to a process of preparation of L-iduronic acid and derivatives comprising a decarboxylation/intramolecular cyclisation tandem reaction. The present invention also relates to the intermediates of the process,...  
WO/2013/044928A1
The invention relates to a method for making precursors of HMO core structures comprising a step of reacting an N-acetyllactosamine or lacto-N-biose derivative donor with a lactose or N-acetyllactosamine derivative acceptor, wherein the ...  
WO/2013/048227A1
The present invention provides a hapten derivative and conjugate of a natural high intensity sweetener containing hydroxyl groups. The conjugate can be used to produce antibodies specific against the natural high intensity sweetener. The...  
WO/2013/041732A1
The present invention relates to the total chemical synthesis of the monosaccharide 35# (R' = H), the disaccharide 36# (R' ≠ H; R'' = H), the trisaccharide 37# (R' ≠ H; R'' ≠ H; R''' = H) and the tetrasaccharide 1#(R' ≠ H; R'' ...  
WO/2013/041182A1
The patent application relates to a method for producing crystalline idarubicin hydrochloride, comprising the steps of (i) preparing a mixture that contains (a) idarubicin hydrochloride, (b) at least one alcohol selected from the group c...  
WO/2013/042581A1
Provided are: a novel sialo-sugar chain; a process for producing said sialo-sugar chain; and production equipment for said sialo -sugar chain. The novel sialo-sugar chain can be easily and efficiently mass-produced by reacting a sugar wh...  
WO/2013/038430A1
Disclosed herein is 10-α/β-D-Arabinofuranosylundecenes of general Formula (II) or pharmaceutically acceptable salts thereof as anti-mycobacterial agents in vitro; (II) wherein R, R1 and R" are as defined herein in the specification. Th...  
WO/2013/037566A1
The invention provides aqueous liquid pharmaceutical compositions comprising arbekacin and chloride ions. The compositions are well tolerable for use in a method for treatment or prevention of a disease of the upper or lower respiratory ...  
WO/2013/034119A1
The invention relates to phenoxy derivatives having glycosidically bound sugar residues, to pharmaceutical compositions containing such compounds, to the uses of such compounds and compositions, and to methods for producing such compound...  
WO/2013/022985A2
The present invention relates to compounds involved in nematode signaling.  
WO/2013/022345A1
The invention relates to O-acylated O-alkylated monoglycosides, and to their use as plasticizing or coalescing agents for compositions comprising a thermoplastic polymer. The invention further relates to a method for preparing said O-acy...  
WO/2013/022985A3
The present invention relates to compounds involved in nematode signaling.  
WO/2013/020979A1
The present invention relates generally to catechin and epicatechin conjugates of formula (I). For example, a chemical synthesis process for the preparation of catechin and epi-catechin compounds, in particular of catechin and epi-catech...  
WO/2013/019662A1
Provided herein are glycosidic aryl naphthalide lignans compounds, such as justiprocumin A isolated from the plant Justicia gendarussa Burm.f. (Acanthaceae), which are effective in the treatment of AIDS and HIV infections.  
WO/2013/017254A1
The invention relates to a synthetic oligosaccharide representing part of the repeating unit of the Clostridium difficile glycopolymer PS-I and having the sequence of the pentasaccharide a-L-Rhap- ( 1→3 ) -β-D-Glcp- ( 1→4 ) - [a-L-R...  
WO/2013/012737A1
This invention provides new active compounds for pharmaceutical use including cancer treatment, wherein the cancers comprise breast, leukocytic, liver, ovarian, bladder, prostatic, skin, bone, brain, leukemia, lung, colon, CNS, melanoma,...  
WO/2013/008062A1
The present invention relates to a non covalent molecular structure comprising a carbon nanostructure and a pyrene based glycoconjugate (I) which is linked to the said carbon nanostructure by a non covalent link, the said glycoconjugate ...  
WO/2013/004086A1
Provided are a fructosylated mangiferin, a preparation method therefor and a use thereof, wherein the fructosylated mangiferin has a structural formula represented by the following formula (I), the method for preparing the fructosylated ...  
WO/2013/003291A3
The present disclosure provides a sophorolipid composition that can be used for inducing protein expression in a fermentation host. The sophorolipid composition described herein can be prepared from a natural sophorolipid mixture. Acid t...  
WO/2013/002346A1
Provided are: a (meth) allylsilane compound that is chemically bonded to a variety of alcohol derivatives such as saccharides and other polyol derivatives, is a raw material used to cause a substrate to express functionality such as anti...  
WO/2013/000275A1
Disclosed are compounds as shown as general formula (I), derivatives and uses thereof, wherein R1, R2, R3, R4, R5a, R5b, R5c and X have the definition as same as the description.  
WO/2012/175813A1
This invention relates to synthetic oligo- or multivalent beta- 1 - 2 - linked mannooligosaccharide compounds and to their use for modulating T helper (Th) and T regulatory (Treg) cell -mediated immune responses.  
WO/2012/173477A1
Title: Methods for chemical synthesis of biologically active compounds using supramolecular protective groups and novel compounds obtainable thereby. Abstract The invention relates to drug development and synthetic chemistry, in particul...  
WO/2012/172566A2
The present invention relates to novel compounds of Formula (I), their pharmaceutically acceptable derivatives, tautomeric forms, isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to the pr...  
WO/2012/173942A2
Methods and materials for producing organic syringomycin, the methods include culturing a culture of Pseudomonas syringae and a growth medium including glucose, mannitol, histidine, a magnesium source, an iron source, and a buffer with a...  
WO/2012/173942A3
Methods and materials for producing organic syringomycin, the methods include culturing a culture of Pseudomonas syringae and a growth medium including glucose, mannitol, histidine, a magnesium source, an iron source, and a buffer with a...  
WO/2012/167813A1
The present invention relates to a process, comprising the steps of: -pre-cultivating cells of a Candida species capable of producing sophorolactone, until a stationary growth phase is obtained, -cultivating said pre-cultivated cells in ...  

Matches 351 - 400 out of 12,630